BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 22, 2000
View Archived Issues
Antigenics and Aquila complete merger
Read More
Photogen Technologies' PH-10 shows promise for PDT in preclinical studies
Read More
Val-HeFT results reported at AHA sessions
Read More
XTL Biopharmaceuticals and Pharming to codevelop lactoferrin for HCV treatment
Read More
Company Profile: Vasogen
Read More
FDA approves Lovenox for seventh indication
Read More
Ligand's Targretin recommended for approval by CPMP
Read More
Inspire updates product developments during BIO-Europe
Read More
First clinical trial results with Oxford Biomedica's MetXia reported
Read More
Lipitor reduces ischemic events following ACS
Read More
Phase III results reported for Natrecor in CHF
Read More
COPERNICUS results show good efficacy for carvedilol in severe HF
Read More
Novel nucleoside transport inhibitors may overcome limitations of dipyridamole
Read More
Nonanticoagulant heparin derivative designed to exert antiangiogenic activity
Read More
No consistent PKC inhibition or significant MDR reversal in melanoma patients treated with CGP-41251
Read More
Penwest and Celltech complete phase Ia trials with lead pain management candidate
Read More
NCI-EORTC-AACR highlights: E-7070 progresses to phase II based on phase I findings
Read More
Small-molecule JNK inhibitor suppresses joint destruction in rat adjuvant arthritis model
Read More
Evidence of biological and clinical activity emerges from phase I/II trial of AnergiX.RA
Read More
Triple TCR peptide vaccine for MS enters phase I/II trial
Read More
Novel nontaxane tubulin-polymerizing epothilone lactam discovered at BMS
Read More
Mesopram, a specific PDE4 inhibitor: evidence supports clinical development for MS
Read More
Pollinosis-associated genes discovered in Japan
Read More
New series of thymidylate synthase inhibitors designed at Sunesis
Read More
Santen presents novel urea TNF-alpha production inhibitors
Read More
New compounds synthesized at Pfizer act as inhibitors of protein farnesyltransferase
Read More
Selective GABA-A receptor subunit ligands discovered at Merck
Read More
Potent new anti-HIV agents acting on viral protease disclosed in recent patent
Read More
Sulfonamide-based MMP inhibitors in development at Shionogi
Read More